After delay, Roche's Tecentriq Hybreza wins first FDA approval for a subcutaneous PD-L1 drug 0 13.09.2024 18:06 Fiercepharma.com After delay, Roche's Tecentriq Hybreza wins first FDA approval for a subcutaneous PD-L1 drug zbecker Fri, 09/13/2024 - 11:06
